Breakthrough Therapies Transforming Type 1 Diabetes Treatment in 2024

Last week, a 34-year-old woman in Bergamo, Italy, became the first patient to receive a groundbreaking monoclonal antibody treatment designed to delay the onset of type 1 diabetes. The news sent ripples through the global medical community—and it’s a development that hits especially close to home for families in Austin, Texas, where the prevalence of type 1 diabetes has been quietly climbing for years. If you’re one of the thousands of Austinites living with this condition—or caring for someone who is—this isn’t just another medical headline. It’s a signal that the way we think about diabetes prevention and management is on the verge of a seismic shift.

But here’s the thing: while the treatment in Bergamo is making waves, the real question for Austin is what this means for us. How soon will these advancements reach local clinics? Who are the experts already pushing the boundaries of diabetes care in Central Texas? And if you’re newly diagnosed—or watching a loved one navigate the early stages of the disease—where do you even begin to find the right support?

The Science Behind the Headlines: What Happened in Bergamo?

The treatment administered in Bergamo involves teplizumab, a monoclonal antibody that targets the immune system’s T-cells, which are responsible for attacking insulin-producing beta cells in the pancreas. In clinical trials, teplizumab has shown the ability to delay the onset of type 1 diabetes by an average of two to three years in high-risk individuals. For a 34-year-old patient, that’s not just a delay—it’s a window of opportunity to prepare, adapt, and potentially avoid the most severe complications of the disease.

This isn’t the first time monoclonal antibodies have made headlines in diabetes research. In 2022, the FDA approved teplizumab under the brand name Tzield for use in the U.S., marking the first disease-modifying therapy for type 1 diabetes. But the Bergamo case is significant because it represents one of the first real-world applications of the treatment outside of controlled clinical settings. It’s a proof of concept that could accelerate adoption in other countries—including, eventually, the U.S.

For Austin, where the Dell Children’s Medical Center and Seton Healthcare Family have long been at the forefront of pediatric diabetes care, this news is particularly relevant. The city’s growing tech-driven economy has attracted a younger, health-conscious population, but it’s also seen a rise in autoimmune conditions like type 1 diabetes. According to data from the Texas Diabetes Council, Travis County has one of the highest rates of type 1 diabetes diagnoses in the state, with children under 18 accounting for a significant portion of new cases.

Why Austin Should Pay Attention

Type 1 diabetes isn’t just a childhood disease—it’s a lifelong condition that requires constant management. The delay offered by treatments like teplizumab could mean the difference between a child developing diabetes at age 8 versus age 11, or an adult being diagnosed at 30 instead of 27. Those extra years can be critical for mental and emotional preparation, financial planning, and even advancements in research that might lead to a cure.

But here’s the catch: while teplizumab is available in the U.S., it’s not yet widely accessible. The treatment is expensive—costing upwards of $200,000 per course—and insurance coverage remains inconsistent. For Austin families already stretched thin by the cost of insulin, continuous glucose monitors, and other diabetes supplies, this creates a stark divide between what’s possible and what’s practical.

That’s where local expertise comes into play. Austin is home to some of the most innovative endocrinologists and diabetes specialists in the country, many of whom are already exploring ways to craft cutting-edge treatments more accessible. For example, the Livestrong Cancer Institutes at Dell Medical School have been pioneering integrative approaches to chronic disease management, including diabetes. Their work emphasizes not just medical treatment but also lifestyle interventions, mental health support, and community-based resources—all of which could complement therapies like teplizumab.

The Bigger Picture: What This Means for Austin’s Diabetes Community

The Bergamo treatment is a reminder that type 1 diabetes is no longer a condition we’re forced to accept as inevitable. But it’s also a call to action for Austin’s healthcare ecosystem. Here’s what the city’s residents should be watching for in the coming years:

• Expanded Clinical Trials: With institutions like UT Health Austin and Baylor Scott & White Health actively involved in diabetes research, Austin is well-positioned to develop into a hub for clinical trials of new treatments. If teplizumab or similar therapies become more widely available, local participation in these trials could offer early access to breakthroughs.
• Insurance and Policy Changes: The high cost of teplizumab underscores the need for advocacy at both the state and federal levels. Organizations like the American Diabetes Association’s Central Texas chapter are already pushing for policies that improve affordability and access to diabetes care. Expect to see more grassroots efforts to pressure insurers and lawmakers to cover these treatments.
• Holistic Care Models: Austin’s reputation as a wellness-forward city means local providers are increasingly focused on holistic approaches to diabetes management. This includes everything from nutrition counseling at places like Natural Grocers on South Lamar to mental health support groups at The Austin Center for Grief & Loss. The future of diabetes care isn’t just about drugs—it’s about building a support system that addresses the whole person.

If This Affects You in Austin, Here’s Who You Need to Know

Given my background in covering healthcare innovation, I’ve seen firsthand how overwhelming it can be to navigate a new diabetes diagnosis—or even just the fear of one. If you’re in Austin and this news resonates with you, here are the three types of local professionals Consider be connecting with:

Pediatric and Adult Endocrinologists with a Research Focus

Look for specialists affiliated with major research institutions like Dell Medical School or Seton Healthcare Family. These doctors are often involved in clinical trials and have early access to emerging treatments. When choosing a provider, ask:

• Are you currently involved in any clinical trials for type 1 diabetes treatments?
• How do you stay updated on the latest advancements in monoclonal antibody therapies?
• Do you collaborate with nutritionists, mental health professionals, or other specialists to provide comprehensive care?

Pro tip: The Texas Diabetes Institute in San Antonio is a regional leader in diabetes research, and many Austin-based endocrinologists maintain close ties with their team. If your local provider doesn’t have the answers, they may be able to refer you to someone who does.

Certified Diabetes Care and Education Specialists (CDCES)

These are the unsung heroes of diabetes management. A CDCES is a healthcare professional—often a nurse, dietitian, or pharmacist—who has undergone specialized training to help patients navigate the day-to-day challenges of living with diabetes. In Austin, you’ll find them in:

• Hospital-based diabetes education programs (e.g., St. David’s Medical Center)
• Private practices focused on chronic disease management
• Community health centers like CommUnityCare, which offers sliding-scale services

When evaluating a CDCES, prioritize those who:

• Have experience working with both pediatric and adult patients (if you’re a family dealing with multiple diagnoses)
• Are familiar with the latest technology, such as continuous glucose monitors (CGMs) and insulin pumps
• Offer virtual or hybrid appointments, which can be a game-changer for busy families

Patient Advocates and Policy Experts

Navigating insurance denials, prior authorizations, and the high cost of diabetes supplies can perceive like a full-time job. That’s where patient advocates come in. These professionals—often with backgrounds in social work, law, or healthcare administration—specialize in helping patients access the care and resources they need. In Austin, you can find them through:

• Nonprofits like the American Diabetes Association’s Central Texas office
• Hospital-based patient advocacy programs
• Independent advocacy firms that focus on chronic illness

Key questions to ask a potential advocate:

• What’s your success rate in appealing insurance denials for diabetes treatments?
• Do you have experience with Medicaid or Medicare appeals?
• Can you help me navigate clinical trial enrollment or compassionate use programs for new drugs?

One local resource to bookmark: The Texas Health and Human Services Commission offers a diabetes resource directory that includes state-funded programs and financial assistance options.

What’s Next for Austin?

The Bergamo treatment is a milestone, but it’s also a reminder that the fight against type 1 diabetes is far from over. For Austin, the path forward involves three key steps:

1. Stay Informed: Follow organizations like the JDRF Central Texas Chapter and Beyond Type 1 for updates on local research and advocacy efforts. Both groups host regular events, webinars, and support groups that can keep you connected to the latest developments.
2. Advocate for Access: If you or a loved one is affected by type 1 diabetes, consider joining advocacy efforts to improve insurance coverage and reduce the cost of treatments. The Texas Diabetes Council meets quarterly to discuss policy changes, and public testimony can make a difference.
3. Build Your Support Network: Diabetes is a team sport. Whether it’s finding a CDCES who understands your family’s needs or connecting with other parents through Austin’s local chapter of the Diabetes Youth Families (DYF), having a strong support system can make all the difference.

The future of type 1 diabetes care is being written right now—and Austin has a role to play in that story. Whether you’re a parent watching for early signs in your child, an adult newly diagnosed, or a caregiver supporting a loved one, the key is to stay engaged, ask questions, and demand better from the system. Because in a city as innovative as Austin, “good enough” should never be the standard.

Ready to find trusted professionals? Browse our complete directory of top-rated diabetes experts in the Austin area today.